AMPK activation protects against prostate cancer by inducing a catabolic cellular state

Penfold et al. show that AMPK activation protects against prostate cancer progression in vivo. AMPK activation switches prostate cancer cells to a tumor-suppressive catabolic state, increasing PGC1α expression and mitochondrial biogenesis while inhibiting lipogenic potential. In parallel, AMPK inhibits a cell cycle gene network associated with prostate cancer progression.

Read the full article here

Related Articles